Equity Details
Price & Market Data
Price: $6.07
Daily Change: -$0.21 / 3.46%
Daily Range: $5.72 - $6.35
Market Cap: $10,948,016
Daily Volume: 10,824
Performance Metrics
1 Week: -3.80%
1 Month: 2.53%
3 Months: -19.07%
6 Months: -32.63%
1 Year: -0.82%
YTD: -57.93%
About Quoin Pharmaceuticals, Ltd. (QNRX)
Explore Quoin Pharmaceuticals, Ltd. (QNRX)'s performance at a glance. Current price: 6.07, daily change: -$0.21 / 3.46%. Market cap: 10,948,016. Focus on its YTD and 3-month performance.
Company Details
Employees: 4
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.